FLUPHENAZINE HYDROCHLORIDE- fluphenazine hydrochloride injection, solution ABD - İngilizce - NLM (National Library of Medicine)

fluphenazine hydrochloride- fluphenazine hydrochloride injection, solution

fresenius kabi usa, llc - fluphenazine hydrochloride (unii: zou145w1xl) (fluphenazine - unii:s79426a41z) - fluphenazine hydrochloride 2.5 mg in 1 ml - fluphenazine hydrochloride injection, usp is indicated in the management of manifestations of psychotic disorders. fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypnotics and in comatose or severely depressed states.  the presence of blood dyscrasia or liver damage precludes the use of fluphenazine hydrochloride.  fluphenazine hydrochloride is contraindicated in patients who have shown hypersensitivity to fluphenazine; cross-sensitivity to phenothiazine derivatives may occur.

FLUPHENAZINE HYDROCHLORIDE tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

fluphenazine hydrochloride tablet, film coated

carilion materials management - fluphenazine hydrochloride (unii: zou145w1xl) (fluphenazine - unii:s79426a41z) - fluphenazine hydrochloride 5 mg - fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypnotics, and in comatose or severely depressed states. the presence of blood dyscrasia or liver damage precludes the use of fluphenazine hydrochloride. fluphenazine hydrochloride is contraindicated in patients who have shown hypersensitivity to fluphenazine; cross-sensitivity to phenothiazine derivatives may occur.

Fluphenazine  Injection BP (FLUVITA) Kenya - İngilizce - Pharmacy and Poisons Board

fluphenazine injection bp (fluvita)

reddys pharma limited off mombasa road, masai road, nairobi kenya - fluphenazine decanoate bp - injection - fluphenazine decanoate bp 25mg/ml - fluphenazine

PMS-FLUPHENAZINE DECANOATE INJ (BP)  25MG/ML LIQUID Kanada - İngilizce - Health Canada

pms-fluphenazine decanoate inj (bp) 25mg/ml liquid

pharmascience inc - fluphenazine decanoate - liquid - 25mg - fluphenazine decanoate 25mg - phenothiazines

PMS-FLUPHENAZINE DECANOATE LIQUID Kanada - İngilizce - Health Canada

pms-fluphenazine decanoate liquid

pharmascience inc - fluphenazine decanoate - liquid - 100mg - fluphenazine decanoate 100mg - phenothiazines

PERPHENAZINE tablet film coated ABD - İngilizce - NLM (National Library of Medicine)

perphenazine tablet film coated

american health packaging - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

PERPHENAZINE tablet film coated ABD - İngilizce - NLM (National Library of Medicine)

perphenazine tablet film coated

clinical solutions wholesale - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

PERPHENAZINE tablet film coated ABD - İngilizce - NLM (National Library of Medicine)

perphenazine tablet film coated

cardinal health - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

PERPHENAZINE tablet film coated ABD - İngilizce - NLM (National Library of Medicine)

perphenazine tablet film coated

clinical solutions wholesale, llc - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

PERPHENAZINE tablet, film coated ABD - İngilizce - NLM (National Library of Medicine)

perphenazine tablet, film coated

remedyrepack inc. - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their components, or related compounds. perphenazine products are also contraindicated in patients with suspected or established subcortical brain damage, with or without hypothalamic damage, since a hyperthermic reaction with temperatures in excess of 104°f may occur in such patients, sometimes not until 14 to 16 hours after drug administration. total body ice-packing is recommended for such a reaction; antipyretics may also be useful.